381 related articles for article (PubMed ID: 12685517)
1. Mechanism of action of methylphenidate: insights from PET imaging studies.
Volkow ND; Fowler JS; Wang G; Ding Y; Gatley SJ
J Atten Disord; 2002; 6 Suppl 1():S31-43. PubMed ID: 12685517
[TBL] [Abstract][Full Text] [Related]
2. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.
Volkow ND; Wang GJ; Fowler JS; Logan J; Franceschi D; Maynard L; Ding YS; Gatley SJ; Gifford A; Zhu W; Swanson JM
Synapse; 2002 Mar; 43(3):181-7. PubMed ID: 11793423
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD.
Swanson JM; Volkow ND
Behav Brain Res; 2002 Mar; 130(1-2):73-8. PubMed ID: 11864720
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.
Volkow ND; Wang G; Fowler JS; Logan J; Gerasimov M; Maynard L; Ding Y; Gatley SJ; Gifford A; Franceschi D
J Neurosci; 2001 Jan; 21(2):RC121. PubMed ID: 11160455
[TBL] [Abstract][Full Text] [Related]
5. Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies.
Volkow ND; Fowler JS; Wang GJ; Ding YS; Gatley SJ
Eur Neuropsychopharmacol; 2002 Dec; 12(6):557-66. PubMed ID: 12468018
[TBL] [Abstract][Full Text] [Related]
6. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.
Volkow ND; Wang GJ; Fowler JS; Ding YS
Biol Psychiatry; 2005 Jun; 57(11):1410-5. PubMed ID: 15950015
[TBL] [Abstract][Full Text] [Related]
7. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain.
Volkow ND; Wang GJ; Fowler JS; Telang F; Maynard L; Logan J; Gatley SJ; Pappas N; Wong C; Vaska P; Zhu W; Swanson JM
Am J Psychiatry; 2004 Jul; 161(7):1173-80. PubMed ID: 15229048
[TBL] [Abstract][Full Text] [Related]
8. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
[TBL] [Abstract][Full Text] [Related]
9. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate.
Cheon KA; Ryu YH; Kim JW; Cho DY
Eur Neuropsychopharmacol; 2005 Jan; 15(1):95-101. PubMed ID: 15572278
[TBL] [Abstract][Full Text] [Related]
10. Does chirality matter? pharmacodynamics of enantiomers of methylphenidate in patients with attention-deficit/hyperactivity disorder.
Quinn D
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S62-6. PubMed ID: 18480679
[TBL] [Abstract][Full Text] [Related]
11. Genetic imaging study with [Tc-
Akay AP; Kaya GÇ; Kose S; Yazıcıoğlu ÇE; Erkuran HÖ; Güney SA; Oğuz K; Keskin D; Baykara B; Emiroğlu Nİ; Eren MŞ; Kızıldağ S; Ertay T; Özsoylu D; Miral S; Durak H; Gönül AS; Rohde LA
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():294-300. PubMed ID: 29684537
[TBL] [Abstract][Full Text] [Related]
12. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD.
Volkow ND; Swanson JM
Am J Psychiatry; 2003 Nov; 160(11):1909-18. PubMed ID: 14594733
[TBL] [Abstract][Full Text] [Related]
13. Serum and brain concentrations of methylphenidate: implications for use and abuse.
Swanson JM; Volkow ND
Neurosci Biobehav Rev; 2003 Nov; 27(7):615-21. PubMed ID: 14624806
[TBL] [Abstract][Full Text] [Related]
14. Areas of the brain modulated by single-dose methylphenidate treatment in youth with ADHD during task-based fMRI: a systematic review.
Czerniak SM; Sikoglu EM; King JA; Kennedy DN; Mick E; Frazier J; Moore CM
Harv Rev Psychiatry; 2013; 21(3):151-62. PubMed ID: 23660970
[TBL] [Abstract][Full Text] [Related]
15. Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths.
Leddy JJ; Waxmonsky JG; Salis RJ; Paluch RA; Gnagy EM; Mahaney P; Erbe R; Pelham WE; Epstein LH
J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):127-36. PubMed ID: 19364291
[TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
[TBL] [Abstract][Full Text] [Related]
17. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.
Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Logan J; Ding YS; Hitzemann R; Pappas N
Am J Psychiatry; 1998 Oct; 155(10):1325-31. PubMed ID: 9766762
[TBL] [Abstract][Full Text] [Related]
18. A post hoc analysis of d-threo-methylphenidate hydrochloride (focalin) versus d,l-threo-methylphenidate hydrochloride (ritalin).
Weiss M; Wasdell M; Patin J
J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1415-21. PubMed ID: 15502601
[TBL] [Abstract][Full Text] [Related]
19. Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.
Volkow ND; Wang GJ; Tomasi D; Kollins SH; Wigal TL; Newcorn JH; Telang FW; Fowler JS; Logan J; Wong CT; Swanson JM
J Neurosci; 2012 Jan; 32(3):841-9. PubMed ID: 22262882
[TBL] [Abstract][Full Text] [Related]
20. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
